Circadia Health

Circadia Health is a startup with a mission to save lives using AI-powered contactless monitoring. The company, established in 2016 and headquartered in the United States, has developed the world's first FDA-cleared truly contactless patient monitoring system. This groundbreaking technology allows for the monitoring of a patient's respiratory rate from up to 8 feet away without the need for any physical contact with the bed or body. This innovation enables early detection, which, in turn, improves clinical outcomes. Circadia's technology has the capability to identify potential medical events such as Congestive Heart Failure, COPD Exacerbations, Pneumonia, Sepsis, UTIs, and Falls several hours or even days in advance. The company's system is complemented by a team of virtual nurses who analyze the data from the device and trends in the patient's electronic health record, providing personalized, predictive risk alerts 24/7/365. The last round of funding for Circadia Health was a Series A investment on 31 August 2021, with the investment coming from SOSV. The startup operates in the AI, Analytics, and Medical Devices industries, positioning itself at the intersection of technology and healthcare, with a focus on leveraging advanced AI capabilities to revolutionize patient monitoring and proactive healthcare management.